Elaine S. Jaffe
0000-0003-4632-0301
Publication & Citation Trends
Publications
0 total
A phase 1 trial of romidepsin, azacitidine, dexamethasone and lenalidomide in relapsed or refractory T-cell lymphoma.
Cited by 0
Semantic Scholar
Pediatric-Type Follicular Lymphoma of the Conjunctiva: Shared Histologic and Molecular Features With the Nodal Counterpart.
Cited by 1
Semantic Scholar
The anti‐CD47 antibody magrolimab with obinutuzumab and venetoclax in relapsed or refractory indolent B‐cell lymphomas
Cited by 3
Semantic Scholar
Response-adapted Phase 2 study of acalabrutinib window prior to frontline chemotherapy in untreated large B-cell lymphoma: Molecular correlates of response to acalabrutinib
Cited by 2
Semantic Scholar
Phase 2 study of alemtuzumab and dose-adjusted EPOCH-R in relapsed or refractory aggressive B-cell lymphomas
Cited by 0
Semantic Scholar
Gene expression profiling reveals two overarching types of ALCL with distinct targetable biology: an LLMPP study.
Cited by 1
Semantic Scholar
Current Concepts in Histiocytic Neoplasms
Cited by 4
Semantic Scholar
Primary Large B-cell Lymphomas of Immune-Privileged Sites.
Cited by 31
Semantic Scholar
Research Topics
Lymphoma Diagnosis and Treatment
(819)
Chronic Lymphocytic Leukemia Research
(329)
Viral-associated cancers and disorders
(324)
CNS Lymphoma Diagnosis and Treatment
(154)
Cutaneous lymphoproliferative disorders research
(133)
Affiliations
Sprint (United States)
Goethe University Frankfurt
University of Southern California
University of Maryland, Baltimore
Oslo University Hospital